Everest Medicines to Announce 2025 Full-Year Financial Results on March 26, 2026
SHANGHAI, March 10, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today...
DPC Dash-Domino's Pizza China Successfully Completes 2025 Full-Year Store Expansion with Outstanding Performance and Innovation
HONG KONG, Jan. 9, 2026 /PRNewswire/ -- DPC Dash – Domino's Pizza China ("DPC Dash" or the "Company") (1405.HK), the exclusive master franchisee for Domino's Pizza in the Chinese Mainland, Hong Kong SAR, and Macau SAR, continued its strong growth...